Semaglutide biosimilar(Taiji Group Chongqing Fuling Pharma)
司美格鲁肽生物类似药（太极集团重庆涪陵制药厂）
Report date: 2026/04/08 15:41:55
Base Information
Drug NameSemaglutide biosimilar(Taiji Group Chongqing Fuling Pharma)
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTaiji Group Chongqing Fuling Pharmaceutical Factory Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesTaiji Group Chongqing Fuling Pharmaceutical Factory Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A